To see all protocols that comply with the WHO Essential Medicine List 

Patients with leukaemia should be considered for inclusion into clinical trials. Link to ALLG website and ANZCTR website.

This treatment should only be carried out in a major centre as intense monitoring and support is required

Units are encouraged to enrol eligible patients (age 15 to 40) on the currently active ALLG ALL6 protocol, which is very close to BFM2000 and currently the ANZCHOG paediatric protocol

The information contained in this protocol is based on the highest level of available evidence and consensus of the eviQ reference committee regarding their views of currently accepted approaches to treatment. Any clinician (medical oncologist, haematologist, radiation oncologist, medical physicist, radiation therapist, pharmacist or nurse) seeking to apply or consult this protocol is expected to use independent clinical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use is subject to eviQ’s disclaimer available at

Send feedback for this page

First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

14 Oct 2019